<DOC>
	<DOCNO>NCT00833339</DOCNO>
	<brief_summary>The investigator propose conduct randomize double-blind , parallel-group , placebo-controlled trial mifepristone veterans military-related posttraumatic stress disorder ( PTSD ) . This study examine clinical , neuropsychological , neuroendocrine effect short-term treatment mifepristone ( 600 mg/day one week ) determine treatment efficacious improve PTSD symptom , cognitive functioning , related clinical measure . Additionally , investigator observe whether baseline neuroendocrine activity , clinical neuropsychological factor predict response mifepristone , whether mifepristone-induced change neuroendocrine activity associate treatment outcome .</brief_summary>
	<brief_title>Trial Mifepristone Combat Veterans With Posttraumatic Stress Disorder</brief_title>
	<detailed_description />
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Mifepristone</mesh_term>
	<criteria>Subject male U.S. veteran Subject expose combat another criterion A traumatic event military service Subject meet diagnostic criterion chronic PTSD Veteran history adrenal insufficiency plasma cortisol level le 5 mcg/dl screen Veteran moderatesevere traumatic brain injury , history stroke , another neurological illness injury likely impact cognitive functioning Veteran diabetes mellitus , endocrinopathy , another major medical illness . Veteran take oral corticosteroid Veteran lifetime diagnosis schizophrenia , schizoaffective disorder , bipolar disorder Veteran currently suicidal otherwise need urgent clinical care Veteran currently receive specialize traumafocused psychotherapy ( i.e. , prolonged exposure , cognitive processing therapy eye movement desensitization reprocess ) . Veteran willing use effective mean birth control study 90 day take study medication Veteran history allergic reaction mifepristone</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>